Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data
Function-impairing polymorphisms of the hepatic uptake transporter SLCO1B1 modify the therapeutic efficacy of statins in a population-based cohort
Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation
Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer
Combined effects of hepatocyte nuclear factor 4α and constitutive androstane receptor on stable warfarin doses
PharmGKB summary : very important pharmacogene information for CYP4F2
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c : Corrigendum